Cargando…

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Rationale: Blood eosinophil counts are used to inform diagnosis/management of eosinophilic asthma. Objectives: Examine blood eosinophil variability and identify factors affecting eosinophil levels to inform clinical interpretation. Methods: Post hoc analysis to understand eosinophil variability usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chipps, Bradley E., Jarjour, Nizar, Calhoun, William J., Iqbal, Ahmar, Haselkorn, Tmirah, Yang, Ming, Brumm, Jochen, Corren, Jonathan, Holweg, Cecile T. J., Bafadhel, Mona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641810/ https://www.ncbi.nlm.nih.gov/pubmed/33891831 http://dx.doi.org/10.1513/AnnalsATS.202010-1249OC

Ejemplares similares

Interleukin-13 in Asthma and Other Eosinophilic Disorders
por: Doran, Emma, et al.
Publicado: (2017)

The global burden of illness of peanut allergy: A comprehensive literature review
por: Lieberman, Jay A., et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF
por: Kelly, Elizabeth A., et al.
Publicado: (2016)

Incidence of anaphylaxis and accidental peanut exposure: A systematic review
por: Muraro, Antonella, et al.
Publicado: (2021)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
por: Ashdown, Helen F., et al.
Publicado: (2021)

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort
por: Chipps, Bradley E., et al.
Publicado: (2012)

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses
por: Iqbal, Ahmar, et al.
Publicado: (2015)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
por: Camp, James, et al.
Publicado: (2018)

Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma
por: Chen, Meng, et al.
Publicado: (2021)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Autophagy Protects against Eosinophil Cytolysis and Release of DNA
por: Esnault, Stephane, et al.
Publicado: (2022)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
por: Hambleton, Kirsty, et al.
Publicado: (2017)

Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States
por: Graham, Robert J., et al.
Publicado: (2023)

Elevated fractional exhaled nitric oxide and blood eosinophil counts are associated with a 17q21 asthma risk allele in adult subjects
por: Schwantes, Elizabeth A, et al.
Publicado: (2017)

Matrix Metalloproteinase-9-Dependent Release of IL-1β by Human Eosinophils
por: Esnault, Stephane, et al.
Publicado: (2019)

Periostin levels and eosinophilic inflammation in poorly-controlled asthma
por: Simpson, Jodie L., et al.
Publicado: (2016)

Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma
por: Murphy, Thomas R., et al.
Publicado: (2022)

The stability of blood Eosinophils in chronic obstructive pulmonary disease
por: Long, Gabriella H., et al.
Publicado: (2020)

RNA-sequencing analysis of lung primary fibroblast response to eosinophil-degranulation products predicts downstream effects on inflammation, tissue remodeling and lipid metabolism
por: Esnault, Stephane, et al.
Publicado: (2017)

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
por: Bafadhel, Mona, et al.
Publicado: (2020)

Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis
por: LaCamera, Peter P, et al.
Publicado: (2019)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
por: Bafadhel, Mona, et al.
Publicado: (2022)

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
por: Pavord, Ian D, et al.
Publicado: (2021)

Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
por: Wencel, Mark L., et al.
Publicado: (2018)

Interleukin-1α Is a Critical Mediator of the Response of Human Bronchial Fibroblasts to Eosinophilic Inflammation
por: Bernau, Ksenija, et al.
Publicado: (2021)

Eosinophils from Physiology to Disease: A Comprehensive Review
por: Ramirez, Giuseppe A., et al.
Publicado: (2018)

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma
por: Casale, T. B., et al.
Publicado: (2017)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry
por: Gall, Rebecca, et al.
Publicado: (2023)

Identification of Genes Expressed by Human Airway Eosinophils after an In Vivo Allergen Challenge
por: Esnault, Stephane, et al.
Publicado: (2013)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis
por: Rhee, Rennie L., et al.
Publicado: (2018)

An open microfluidic coculture model of fibroblasts and eosinophils to investigate mechanisms of airway inflammation
por: Zeng, Yuting, et al.
Publicado: (2022)

Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients
por: Cai, Cheng-Sen, et al.
Publicado: (2022)

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
por: Liu, Mark C., et al.
Publicado: (2021)

Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis
por: Harrold, Leslie R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6mhtkdrcaj3o9sik7lep4d9gkj